Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis
暂无分享,去创建一个
S. Dedhar | S. Gallinger | A. Marotta | B. Salh | D. Owen | J. Sanghera | B. Dupuis | V. Gray | C. Tan | Saleem Malik
[1] S. Dedhar,et al. Inhibition of integrin linked kinase (ILK) suppresses β-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC−/− human colon carcinoma cells , 2001, Oncogene.
[2] H. Akashi,et al. Growth‐suppressive effect of non‐steroidal anti‐inflammatory drugs on 11 colon‐cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac , 2000, International journal of cancer.
[3] S. Dedhar,et al. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9) , 2000, Oncogene.
[4] W. Franklin,et al. Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. , 2000, Carcinogenesis.
[5] L. Donehower,et al. The Integrin-linked Kinase Regulates the Cyclin D1 Gene through Glycogen Synthase Kinase 3β and cAMP-responsive Element-binding Protein-dependent Pathways* , 2000, The Journal of Biological Chemistry.
[6] S. Dedhar,et al. The integrin-linked kinase (ILK) suppresses anoikis , 2000, Oncogene.
[7] S. Dey,et al. Host cyclooxygenase-2 modulates carcinoma growth. , 2000, The Journal of clinical investigation.
[8] A. Hsu,et al. The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2* , 2000, The Journal of Biological Chemistry.
[9] J Straub,et al. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Dedhar,et al. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Kinzler,et al. PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.
[12] R. Gaynor,et al. Sulindac Inhibits Activation of the NF-κB Pathway* , 1999, The Journal of Biological Chemistry.
[13] H. Clevers,et al. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. , 1999, Science.
[14] C. Albanese,et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] Paul Polakis,et al. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.
[16] W F Bodmer,et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Woodgett,et al. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Sparks,et al. Identification of c-MYC as a target of the APC pathway. , 1998, Science.
[19] W. Birchmeier,et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.
[20] S. Dedhar,et al. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] Bert Vogelstein,et al. Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .
[22] Gerhard Christofori,et al. A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.
[23] K. Kinzler,et al. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Dedhar,et al. Integrin-linked Protein Kinase Regulates Fibronectin Matrix Assembly, E-cadherin Expression, and Tumorigenicity* , 1998, The Journal of Biological Chemistry.
[25] M. Mcentee,et al. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. , 1997, Cancer research.
[26] S. Dedhar,et al. Overexpression of the Integrin-linked Kinase Promotes Anchorage-independent Cell Cycle Progression* , 1997, The Journal of Biological Chemistry.
[27] K. Kinzler,et al. Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.
[28] K. Kinzler,et al. Sulindac suppresses tumorigenesis in the Min mouse. , 1996, Carcinogenesis.
[29] B. Rigas,et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. , 1996, Biochemical pharmacology.
[30] Paul Polakis,et al. Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.
[31] S. Dedhar,et al. Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase , 1996, Nature.
[32] B. Rigas,et al. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. , 1995, The Journal of clinical investigation.
[33] R. Coffey,et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.
[34] P. Vielh,et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.
[35] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[36] O. Issinger,et al. Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. , 1990, European journal of biochemistry.
[37] Kathleen R. Cho,et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.
[38] H. Clevers,et al. The Yin-Yang of TCF/beta-catenin signaling. , 2000, Advances in cancer research.
[39] A. Marotta,et al. Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer. , 1999, Anticancer research.